---
category: listing
circular_id: f840956cf79aebea
date: '2025-12-16'
description: NSE notifies listing and trading of 8.37 crore equity shares of Dr. Lal
  Path Labs Limited pursuant to bonus issue, effective December 23, 2025.
draft: false
guid: https://nsearchives.nseindia.com/content/circulars/CML71828.pdf
impact: medium
impact_ranking: medium
importance_ranking: medium
justification: Routine bonus issue listing for a publicly traded company. Impacts
  existing shareholders and trading activity but is a standard corporate action.
pdf_url: https://nsearchives.nseindia.com/content/circulars/CML71828.pdf
processing:
  attempts: 1
  content_hash: a6303ad2eef64059
  processed_at: '2025-12-16T15:59:57.472071'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2025-12-16T00:00:00+05:30'
rss_url: https://nsearchives.nseindia.com/content/circulars/CML71828.pdf
severity: medium
source: nse
stocks:
- LALPATHLAB
tags:
- bonus-issue
- listing
- equity-shares
- capital-market
- corporate-action
title: Listing & Trading of Equity Shares pursuant to Bonus Issue of Dr. Lal Path
  Labs Limited
---

## Summary

National Stock Exchange of India has issued a circular notifying the listing and trading of equity shares of Dr. Lal Path Labs Limited pursuant to a bonus issue. A total of 8,37,75,510 equity shares will be admitted to dealings on the NSE Capital Market segment with effect from December 23, 2025. The new shares have been allotted under ISIN INE600L01024 with distinctive numbers ranging from 83775511 to 167551020.

## Key Points

- Company: Dr. Lal Path Labs Limited (Symbol: LALPATHLAB)
- Number of bonus shares issued: 8,37,75,510 equity shares
- ISIN: INE600L01024
- Record date for bonus issue: December 19, 2025
- Deemed date of allotment: December 22, 2025
- Trading commencement date: December 23, 2025
- Distinctive number range: 83775511 to 167551020
- Circular issued under Regulation 3.1.1 of NSE (Capital Market) Trading Regulations Part A

## Regulatory Changes

No regulatory changes introduced. This circular notifies the admission of additional securities pursuant to a bonus issue in accordance with existing NSE trading regulations.

## Compliance Requirements

- Members must identify the security by its designated codes (Symbol: LALPATHLAB, ISIN: INE600L01024) for trading purposes on the system
- Trading members should update their systems to reflect the increased share capital
- All trading activities for these securities must comply with NSE (Capital Market) Trading Regulations Part A

## Important Dates

- **December 16, 2025**: Circular issued by NSE
- **December 19, 2025**: Record date for bonus issue eligibility
- **December 22, 2025**: Deemed date of allotment of bonus shares
- **December 23, 2025**: Effective date for listing and trading of bonus shares on NSE

## Impact Assessment

**Market Impact**: The bonus issue will increase the outstanding share capital of Dr. Lal Path Labs Limited, potentially improving liquidity in the stock. The per-share price will adjust proportionally to reflect the increased number of shares.

**Trading Impact**: Existing shareholders will see their holdings increase based on the bonus ratio (not specified in the circular). Trading volumes may increase due to enhanced liquidity.

**Operational Impact**: Brokers and trading members need to ensure their systems are updated to reflect the new share count and adjusted pricing. Investors holding shares as of the record date (December 19, 2025) will receive bonus shares credited to their demat accounts.